Stage IV Melanoma Active Not Recruiting Phase 1 / 2 Trials for Ipilimumab (DB06186)

IndicationStatusPhase
DBCOND0028660 (Stage IV Melanoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02073123Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic MelanomaTreatment